JF
JBIO

Jump Financial’s Jade Biosciences JBIO Stock Holding History

Jump Financial’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.84M Buy
172,747
+160,947
+1,364% +$3.36M 0.03% 614
2026
Q1 		$166K Buy
+11,800
New +$171K ﹤0.01% 1699
2024
Q2 		– Sell
-274
Closed -$284K – 1802
2024
Q1 		$284K Buy
+274
New +$209K 0.01% 1475

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Financial's JBIO Position: Q2 2026 in Review

Jump Financial increased its Jade Biosciences (JBIO) stake by 1,364% in Q2 2026, buying an estimated $3.36M and bringing the position to 172,747 shares worth $3.84M. The position accounts for 0.03% of the portfolio, ranked #614.

Jump Financial first reported a position in JBIO in Q1 2024 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Jump Financial held 172,747 shares of Jade Biosciences worth $3.84M as of Q2 2026.
  • Jump Financial bought 160,947 Jade Biosciences shares in Q2 2026, an estimated $3.36M.
  • Jade Biosciences made up 0.03% of Jump Financial's portfolio in Q2 2026, its #614 holding.
  • Jump Financial first reported a position in Jade Biosciences in Q1 2024 and has held it in 3 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.